Coral Laboratories Stock Screener | Share Price & Fundamental Analysis
CORALAB
Pharmaceuticals
Screen Coral Laboratories share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹444.25
▼
-9.95 (-2.19%)
Market Cap
₹168.92 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
0.76
EPS (TTM)
₹67.61
Dividend Yield
-
Debt to Equity
0.01
52W High
₹808.65
52W Low
₹438.50
Operating Margin
18.00%
Profit Margin
17.17%
Revenue (TTM)
₹99.00
EBITDA
₹25.00
Net Income
₹17.00
Total Assets
₹230.00
Total Equity
₹201.00
Coral Laboratories Share Price History - Stock Screener Chart
Screen CORALAB historical share price movements with interactive charts. Analyze price trends and patterns.
Coral Laboratories Company Profile - Fundamental Screener
Screen Coral Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for CORALAB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE683E01017
Coral Laboratories Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen CORALAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 230 | 206 | 174 | 190 | 168 | 144 | 136 | 140 | 131 | 90 |
| Current Assets | 177 | 154 | 124 | 131 | 129 | 96 | 84 | 72 | 74 | 65 |
| Fixed Assets | 23 | 24 | 25 | 24 | 21 | 23 | 23 | 22 | 18 | 18 |
| Liabilities | ||||||||||
| Total Liabilities | 230 | 206 | 174 | 190 | 168 | 144 | 136 | 140 | 131 | 90 |
| Current Liabilities | 3 | 3 | 8 | 8 | 3 | 4 | 4 | 4 | 4 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 201 | 178 | 155 | 156 | 137 | 116 | 114 | 116 | 109 | 70 |
| Share Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves & Surplus | 198 | 174 | 151 | 153 | 133 | 112 | 110 | 113 | 106 | 67 |
Screen CORALAB income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 99 | 124 | 90 | 85 | 80 | 100 | 77 | 96 | 97 | 99 | 80 | 62 |
| Expenses | 74 | 89 | 67 | 74 | 67 | 81 | 65 | 79 | 77 | 72 | 61 | 47 |
| EBITDA | 25 | 35 | 23 | 11 | 13 | 20 | 11 | 17 | 20 | 27 | 19 | 15 |
| Operating Profit % | 18.00% | 23.00% | 19.00% | 5.00% | 11.00% | 16.00% | 8.00% | 13.00% | 16.00% | 24.00% | 21.00% | 21.00% |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 23 | 33 | 21 | 8 | 12 | 18 | 9 | 16 | 18 | 25 | 17 | 12 |
| Tax | 6 | 8 | 5 | 2 | 3 | 4 | 2 | 5 | 6 | 8 | 5 | 3 |
| Net Profit | 17 | 24 | 16 | 6 | 9 | 14 | 7 | 10 | 12 | 16 | 12 | 10 |
| EPS | 48.60 | 67.61 | 44.19 | 18.04 | 25.32 | 37.94 | 19.96 | 28.60 | 34.84 | 45.61 | 34.70 | 26.79 |
Coral Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen CORALAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -1 | -6 | 13 | 6 | 1 | -4 | -1 | 14 | 11 | 5 |
| Investing Activities | 0 | 1 | -3 | -6 | 0 | -2 | 3 | -13 | -10 | -3 |
| Financing Activities | 3 | 0 | -6 | 0 | 0 | 4 | -1 | -3 | 1 | 0 |
| Net Cash Flow | 1 | -4 | 4 | 0 | 1 | -2 | 1 | -2 | 2 | 2 |
Screen CORALAB shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% | 71.51% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.14% | 0.23% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 20.91% | 20.76% | 20.80% | 20.82% | 20.33% | 21.18% | 20.99% | 21.24% |
| Other Holding | 7.58% | 7.72% | 7.69% | 7.52% | 7.93% | 7.31% | 7.50% | 7.25% |
| Shareholder Count | 4,105 | 4,213 | 4,286 | 4,098 | 3,831 | 3,949 | 4,054 | 4,046 |
Coral Laboratories Dividend Screener - Share Yield Analysis
Screen CORALAB dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹2.00 | 2.04% |
| 2018-March | ₹2.00 | 0.63% |
| 2017-March | ₹5.00 | 0.84% |
| 2016-March | ₹0.00 | 0.00% |
Coral Laboratories Index Membership - Market Screener Classification
Screen CORALAB by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Coral Laboratories Market Events Screener - Corporate Actions
Screen CORALAB market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 1.50 /share | -28.37% | ||
| Annual General Meeting | NA | 21.88% | ||
| Dividend | ₹ 2.00 /share | 23.19% | ||
| Annual General Meeting | NA | -5.28% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 0.41% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -3.21% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 4.18% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -8.05% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -2.11% |
Coral Laboratories Competitors Screener - Peer Comparison
Screen CORALAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 424,634 | 39.93 | 54,729 | 9.71% | 10,980 | 49.55 |
| Divis Laboratories | 172,860 | 69.20 | 9,712 | 18.67% | 2,191 | 56.33 |
| Torrent Pharmaceuticals | 129,151 | 60.10 | 11,539 | 6.99% | 1,911 | 61.47 |
| Cipla | 122,205 | 22.55 | 28,410 | 7.12% | 5,291 | 49.47 |
| Dr Reddys Laboratories | 107,114 | 18.60 | 33,741 | 16.73% | 5,725 | 60.05 |
| Lupin | 97,120 | 22.34 | 22,910 | 13.74% | 3,306 | 65.28 |
| Zydus Life Science | 92,392 | 18.40 | 23,511 | 18.55% | 4,615 | 40.07 |
| Mankind Pharma | 90,241 | 50.59 | 12,744 | 20.90% | 2,007 | 45.53 |
| Aurobindo Pharma | 71,119 | 20.79 | 32,346 | 9.43% | 3,484 | 59.88 |
| Alkem Laboratories | 67,243 | 27.59 | 13,458 | 3.70% | 2,216 | 49.80 |
Coral Laboratories Company Announcements - News Screener
Screen CORALAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-14 | Results - Financial Results For Quarter And Half Year Ended September 30 2025 | View |
| 2025-11-14 | Board Meeting Outcome for Outcome Of The Board Meeting Held On November 14 2025 Pursuant To Regulation 30 (Read With Part A Of Schedule III) The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations") | View |
| 2025-11-07 | Board Meeting Intimation for Notice Under Regulation 29(1) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-10-13 | Outcome Of The Board Meeting Held On October 13 2025 For Capacity Expansion At The Plant Located At Dehradun Corrigendum To Announcement Under Regulation 30 Of The SEBI (LODR) 2015 | View |
| 2025-10-13 | Intimation Regarding Capacity Addition Under Regulation 30 (Read With Part A Of Schedule III) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-10-13 | Board Meeting Outcome for Outcome Of The Board Meeting Held On October 13 2025 For Capacity Expansion At The Plant Located At Dehradun | View |
| 2025-10-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-26 | Combined Scrutinizer Report For Remote E-Voting And Voting At The AGM Carried Out For The 43Rd Annual General Meeting Of The Company Held On Friday September 26 2025. | View |
| 2025-09-26 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-25 | Board Meeting Outcome for Outcome Of The Board Meeting Held On September 25 2025 Pursuant To Regulation 30 (Read With Part A Of Schedule III) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-09-25 | Board Meeting Outcome for Outcome Of The Board Meeting Held On September 25 2025 Pursuant To Regulation 30 (Read With Part A Of Schedule III) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-09-24 | Closure of Trading Window | View |
| 2025-09-20 | Board Meeting Intimation for Notice Under Regulattion 29(1) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-09-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-03 | Notice Convening The 43Rd Annual General Meeting (AGM) And The Annual Report For Financial Year 2024-2025. | View |
| 2025-09-03 | Reg. 34 (1) Annual Report. | View |
| 2025-09-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-30 | Notice Of Book Closure | View |
| 2025-08-30 | Notice Of Book Closure & Record Date | View |
| 2025-08-30 | Notice Of Book Closure & Record Date | View |